Skip to Main Content

HSLIC News

HSLIC's Biomedical Informatics Seminar Series presents: Christophe Lambert, PhD

by Tamara Wheeler on 2021-02-15T09:40:00-07:00 | 0 Comments

Image containing following text: HSLIC's Biomedical Informatics Seminar Series presents: Christophe Lambert, PhD - Thursday, 2/18/2021 at 10:00 AM via Zoom.You are invited to join us on Thursday, February 18, 2021, 10 – 11 AM, for an intriguing seminar by Christophe Lambert, PhD, Associate Professor, Department of Internal Medicine, Center for Global Health, Division of Translational Informatics. 

Dr. Lambert will present on A Validated Machine Learning Model of Conversion from Major Depressive Disorder to Bipolar Disorder.

This will be a virtual seminar hosted via Zoom. Please register in advance here: https://hsc-unm.zoom.us/meeting/register/tJwsdOispjkvHN2XTPtGTajxOUnPfI_yWzsd  

Background: A high fraction of patients with bipolar disorder are first diagnosed with major depressive disorder, and may receive inappropriate treatment. Starting with a complex set of thousands of variables, we created a parsimonious 9-variable machine learning model using 5 large-scale US patient record databases, and successfully validated it across 8 national and international databases. The model can be scored with a pencil and paper, and provides insight into what factors place patients at higher risk of conversion.

 Learning objectives:

1. To understand how machine learning models can be developed on patient record data, and validated across an international network.
2. To understand factors driving the high conversion rate from an initial diagnosis of major depressive disorder to a subsequent diagnosis of bipolar disorder.

The University of New Mexico School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


 Add a Comment

0 Comments.

  Subscribe



Enter your e-mail address to receive notifications of new posts by e-mail.


  Archive



  Follow Us



  Twitter
  Instagram
  Return to Blog
This post is closed for further discussion.

title
Loading...